September 2016 FDA Recall Bupropion Hydrochloride by Sun Pharmaceutical Industries, Inc.
D-0007-2017 - Failed Dissolution Specifications

This Class III drug recall was voluntarily initiated by Sun Pharmaceutical Industries, Inc. on September 13, 2016 for the product Bupropion Hydrochloride. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0007-2017

Reason for Recall
Failed Dissolution Specifications
Initiated
09-13-2016
Reported
10-12-2016
Quantity
31,762 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Sun Pharmaceutical Industries, Inc.
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, Twice-A-Day, in 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by Sun Pharmaceuticals Ind. Ltd. Halol- Baroda Highway, Halol-389 350, Gujarat, India. UPC 347335737868 NDC 47335-737-86

Batch or Lot Expiration Information

Lot# JKN5124A and JKN5229A, exp 10/2016